Neuroscience

Algernon Pharmaceuticals Announces Increase to Private Placement

VANCOUVER, British Columbia, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or…

12 months ago

IEEE EMBS Executive Committee Appoints Dr. Erika Ross Ellison as President-Elect, Along With Two New Vice Presidents

Dr. Beena Ahmed appointed vice president of Conferences Dr. Natalie Mrachacz-Kersting appointed vice president of Member and Student Activities Two-year…

1 year ago

BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network

BURLINGTON, Mass. and JERUSALEM, Dec. 19, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…

1 year ago

Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory

New accessory for NeuroStar TMS reduces patient setup steps and improves efficiency for providersMALVERN, Pa., Dec. 18, 2023 (GLOBE NEWSWIRE)…

1 year ago

HSG Advisors Expands Claims Data Analytics Services

Leading Healthcare Consultancy Meets Increasing Demand for Data-Driven InsightsLOUISVILLE, KY / ACCESSWIRE / December 15, 2023 / HSG Advisors, a…

1 year ago

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn., Dec. 14, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a…

1 year ago

HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights

Company Appoints Mohammad Shokoohi-Yekta to Lead Program and Industry Pioneer Lance Myers as AdvisorSANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT),…

1 year ago

Lynx.MD and Baptist Health Innovations Collaborate to Advance Medical Research and Development

Initiative enhances Baptist Health South Florida's efforts in medical innovation for advanced research and collaborative development.PALO ALTO, CA / ACCESSWIRE…

1 year ago

BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today

Company to review BXCL502 and other potential emerging pipeline candidates   Dr. Jeffrey Cummings to discuss agitation relief in Alzheimer’s disease and…

1 year ago

Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer

WATERTOWN, Mass., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug…

1 year ago